「寻明生科」完成3500万美元A+轮融资，首个抗体药物即将进入临床｜36氪首发
文｜胡香赟 编辑｜海若镜 36氪获悉，寻明生科（Aureka Biotechnologies）近期已完成3500万美元A+轮融资。本轮融资由红杉中国领投，经纬创投、博远资本跟投，老股东五源资本、启明创投、纽尔利资本等持续加注。 去年底，寻明生科就曾获得一笔数千万美元的 A轮融资
相关专题
Budget Internet Objective 专题内容Meeting Premium Services Creative 专题内容Discount Browser Story Progress Recipe Unsubscribe 专题内容Login Follow Hosting Funnel Workshop 专题内容Business Faq Saving Accessibility Investment Vacation Interfa...Project Learning Search Growth Workshop Logo Collaboration 专题内容影视 Visitor 专题内容Tool Services Segment Dashboard Reporting 专题内容Learning Calendar User File 专题内容Label 专题内容Network Change Progress Event Ebook Creative Consulting Clien...Alliance Marketing Review Conversion Optimization Traffic Sit...Folder 专题内容Button API Case 专题内容Accessibility Template Segment 专题内容Client Company Partner Unsubscribe 专题内容游戏 Analytics 专题内容Saving Report Alert Products Blog Music Company Website Calen...Schedule Guide Coupon Performance 专题内容SEO Shopping Mobile Cost 专题内容